Bioinformatics and Population Sciences

Saro Armenian, D.O., M.P.H.
Saro Armenian, associate professor in the Department of Pediatrics and Population Sciences, is director of the Childhood Cancer Survivorship Clinic. His research focuses on understanding the effect of childhood cancer on cardiovascular disease and on developing strategies for cardiovascular screening of cancer survivors.
 
Kimlin Tam Ashing, Ph.D.
Kimlin Tam Ashing, professor inthe Department of Population Sciences, is director of the Center of Community Alliance for Research & Education. Her focus is directed at understanding how social disparities impact heath and patient centered outcomes with the goal of developing strategies to improve quality of life and reduce health inequities.
 
Leslie Bernstein, Ph.D.
Leslie Bernstein, professor and director of the Division of Biomarkers of Early Detection and Prevention, Department of Population Sciences, received her Ph.D. from UCLA. Her research utilizes data from the California Teachers Study to examine questions of cancer etiology, prevention and the impact of modifiable risk factors.
 
Andrea Bild, Ph.D.
Andrea Bild, professor in the Department of Medical Oncology & Therapeutics Research, received her Ph.D. from University of Colorado Denver. Her research team uses large-scale translational genomic and pharmacological studies to interrogate and treat tumor heterogeneity and evolution to refractory states.
 
Wing-Chun (John) Chan, M.D.
Wing-Chun (John) Chan, the Dr. Norman and Melinda Payson Professor in Hematologic Cancers, received his M.D. from University of Hong Kong. His research focuses on using genomics approaches to explore the molecular pathogenesis and classification of lymphoma. He has identified molecular signature to improve diagnosis, outcome prediction and treatment response for lymphoma patients.
 
Shiuan Chen, Ph.D.
Shiuan Chen, the Lester M. and Irene C. Finkelstein Chair in Biology, received his Ph.D. from University of Hawaii. His team focuses on refining current treatment strategies and available drugs for better application against breast cancer. He also investigates how environmental chemicals and diet modulate the development of hormone-dependent cancers.
 
Betty Ferrell, Ph.D.
Betty Ferrell, professor and director of the Division of Nursing Research and Education, Department of Population Sciences, received her Ph.D. from Texas Woman’s University. She is interested in examining quality of life, pain management and palliative care for cancer patients.
 
John Kaddis, Ph.D.
John Kaddis, assistant professor in the Department of Diabetes & Cancer Discovery Science, received his Ph.D. from USC. He is currently focused on developing data systems and tools to address leading-edge questions relating to type 1 diabetes.
 
Rick Kittles, Ph.D.
Rick Kittles, professor and director of the Division of Health Equities, Department of Populations Sciences, received his Ph.D. from George Washington University. His research interest focuses on genetic and environmental factors and their mechanisms in contributing to disease risks and drug resistance.
 
James Lacey, Ph.D., M.P.H.
James Lacey, associate professor and director of the Divisino of Health Analytics, Department of Computation and Quantitative Medicine, received his Ph.D. from University of Michigan Ann Arbor. He is director of the Division of Cancer Etiology and is currently focused on developing tools to digitize the California Teachers Study database to make access and analysis more efficient.
 
Keane Lai, M.D. 
Keane Lai, associate clinical professor in the Department of Pathology, received his M.D. from University of Pittsburgh. He is interested in defining the role that the Wnt/catenin signaling pathway plays in liver cancer and pancreatic cancer. His laboratory is also working toward identifying novel therapeutic targets in this pathway to combat pancreatic cancer.
 
Jeannine McCune, Pharm.D.
Jeanine McCune, professor in the Department of Population Sciences, received her Pharm.D from University of North Carolina. Her team is currently developing mathematical models to identify anticancer. agent plasma exposure effective at treating cancer and modeling drug doses and frequencies to optimize treatment efficacy.
 
Susan Neuhausen, Ph.D.
Susan Neuhausen, The Morris & Horowitz Families Professor in Cancer Etiology & Outcomes Research, received her Ph.D. from University of Minnesota. Her team focuses on identifying genetic, lifestyle and environmental factors that cause breast, ovarian and prostate cancers, and to uncover what factors are important for disease-free survival in those who develop cancer.
 
Sunita Patel, Ph.D.
Sunita Patel, associate clinical professor in the Department of Population Sciences, received her Ph.D. from Alliant University. She is identifying biological and environmental factors as either risk or protective factors for neurocognitive and psychosocial sequelae in cancer patients. Her work includes behavioral interventions to improve health disparities among ethnic minority survivors of childhood cancer.
 
Anne Reb, Ph.D., N.P.
Anne Reb, assistant professor in the Division of Nursing Research and Education, Department of Population Sciences, received her Ph.D. from the Catholic University of America. Her research is directed at developing models of care to address areas of symptom management and cancer survivorship with particular emphasis on mind-body interventions.
 
Russell Rockne, Ph.D.
Russell Rockne, assistant professor and director of the Divisino of Mathematical Oncology, Department of Computational and Quantitative Medicine, received his Ph.D. from University of Washington. His work is based upon patient-specific mathematical models of cancer growth and response to therapy, with the goal of using mathematical models to quantify and predict disease dynamics and recurrence.
 
Andrei Rodin, Ph.D.
Andrei Rodin, the Dr. Susumu Ohno Chair in Theoretical Biology and associate professor in the Department of Diabetes Complications & Metabolism, received his Ph.D. from University of Texas Health Science Center, Houston. He is developing data analysis methodology and software to analyze large-scale data sets with an emphasis in understanding problems in molecular evolution.
 
Mina Sedrak, M.D., M.S.
Mina Sedrak, assistant professor in the Department of Medical Oncology & Therapeutics Research, received his M.D. from Rush Medical College. He is focused on examining barriers to clinical trial participation for older adults with cancer as a way to improve evidence-based cancer therapy for this population.
 
Victoria Seewaldt, M.D.
Victoria Seewaldt, the Ruth Ziegler Chair in Population Sciences, received her M.D. from UC Davis. Her research focuses on identifying signaling networks that promote breast cancer initiation with the goal of integrating novel functional imaging strategies with risk-marker to provide early detection of interval cancers.
 
Nagarajan Vaidehi, Ph.D.
Nagarajan Vaidehi, chair of the Department of Computational and Quantiative Medicine and professor in the Department of Molecular Imaging & Therapy, received her Ph.D. from Indian Institute of Technology. Her laboratory focuses on developing and applying computational methods to study the structure and dynamics of membrane proteins and protein-protein interactions for identifying small molecule inhibitors.
 
Jeffrey Weitzel, M.D.
Jeffrey Weitzel, the Dr. Norman & Melinda Payson Professor in Medical Oncology and director of the Division of Clinical Cancer Genomics, Department of Population Sciences, received his M.D. from University of Minnesota Medical School. His research is focused on genetic cancer risk assessment, particular in minority populations, which may be under served.
 
F. Lennie Wong, Ph.D.
F. Lennie Wong, associate professor in the departments of Population Sciences and Computational and Quantitative Medicine, Division of Biostatistics, received her Ph.D. from UCLA. She uses computer modeling to address the long-term health issues that childhood cancer survivors may face.